NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE52590 Query DataSets for GSE52590
Status Public on May 01, 2018
Title Heterogeneous DNA methylation changes in acute myeloid leukemia associate with cancer-specific gene expression signatures and disruption of the hematopoietic regulatory network
Organism Homo sapiens
Experiment type Methylation profiling by high throughput sequencing
Summary DNA methylation is known as a stable epigenetic mark that is linked to gene silencing in cancer. Specific sets of DNA methylation changes have been linked to cancer subgroups. Here we generated genome-wide DNA methylation profiles of acute myeloid leukemia (AML) patient samples. A subset of genomic regions showed extensive hypervariation among AML patients. As such, none of the identified differentially methylated regions (DMRs) as compared to normal heamatopoietic precursor cells were common to all AML cases. Gain of methylation is restricted to regions that in human ES cells are marked with both H3K27me3 and H3K4me3 (bivalent marks). These regions are associated with lowly expressed and silent genes in healthy progenitors. Expression changes associated with aberrant methylation occurred infrequently, but revealed a small and highly specific subset of DMRs associated with myeloid function and cancer-specific pathways. Furthermore, loss of DNA methylation in AML specifically targeted a small number modules in heamatopoietic regulatory networks, in a mutually exclusive manner. Our data emphasize the variation in DNA methylation patterns between different AML cases, but shows that among these changes, a core set of changes drives cancer-essential alterations in gene expression and regulation.
 
Overall design To investigate DNA methylation in acute myeloid leukemia (AML) in a genome-wide unbiased fashion, we applied MethylCap-seq. This method involves capture of methylated DNA using the MBD domain of MeCP2, and subsequent next-generation Illumina sequencing of eluted DNA.
 
Contributor(s) Brinkman AB, Simmer F, Kaan A, Altucci L, Stunnenberg HG
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Nov 20, 2013
Last update date May 15, 2019
Contact name Arjen Brinkman
E-mail(s) arjen.brinkman@gmail.com
Organization name Radboud University, Nijmegen Center for Molecular Life Sciences
Department Molecular Biology
Lab Stunnenberg
Street address NCMLS #274, Geert Grooteplein Zuid 30
City Nijmegen
ZIP/Postal code 6525 GA
Country Netherlands
 
Platforms (1)
GPL10999 Illumina Genome Analyzer IIx (Homo sapiens)
Samples (20)
GSM1272237 AML_108
GSM1272238 AML_109
GSM1272239 AML_112b
Relations
BioProject PRJNA229431
SRA SRP033222

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE52590_AML_MethylCap_peaks_hyper_DMRs.txt.gz 4.1 Mb (ftp)(http) TXT
GSE52590_AML_MethylCap_peaks_hypo_DMRs.txt.gz 4.1 Mb (ftp)(http) TXT
GSE52590_AML_MethylCap_peaks_tagcounts.txt.gz 10.1 Mb (ftp)(http) TXT
GSE52590_RAW.tar 2.7 Gb (http)(custom) TAR (of BED, WIG)
SRA Run SelectorHelp
Processed data provided as supplementary file
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap